PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Medical intervention in transgender adolescents appears to be safe and effective

2013-06-17
(Press-News.org) SAN FRANCISCO—Hormone treatment to halt puberty in adolescents with gender identity disorder does not cause lasting harm to their bones, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.

"Hormonal interventions to block the pubertal development of children with gender dysphoria are effective and sufficiently safe to alleviate the stress of gender dysphoria," said the study's lead author, Henriette Delemarre-van de Waal, MD, PhD, a professor of pediatric endocrinology at Leiden University Medical Center, Leiden, The Netherlands.

An adolescent who identifies as the opposite sex—now called transgender or gender dysphoric rather than transsexual—often considers the body changes of puberty to be unbearable, Delemarre-van de Waal said.

"Reversible hormone treatment can relieve the psychological suffering of youth with gender dysphoria and allows the adolescent time to explore whether permanent hormone treatment and sex reassignment surgery is the best option," she said.

Treatment early in puberty—ages 12 to 14 years—with medication called gonadotropin-releasing hormone analogs (a derivative of the physiologic hormone), or GnRHa, blocks production of the sex hormones that bring on puberty and can make slightly developed sex characteristics go away. However, puberty is the time when buildup of bone mass typically occurs.

"There were concerns that blocking the hormones of puberty at the normal age of puberty would have long-term deleterious effects on bone health," Delemarre-van de Waal said.

To study the bone health of adolescents with gender identity disorder who received puberty suppression treatment with GnRHa, the researchers followed up 127 such patients who later chose to receive "cross-sex hormones" to induce sexual characteristics of the opposite sex. Fifty-three boys transitioned to the female sex by taking estrogen, and 73 girls transitioned to the male sex by receiving testosterone, the authors reported. They received cross-sex hormones beginning at age 16 years. This age is in agreement with Dutch law and The Endocrine Society guidelines for treating transgender persons, which Delemarre-van de Waal helped develop.

Suppression of puberty was well received, according to Delemarre-van de Waal. The patients reported satisfaction and no regrets regarding suppression of puberty. However, many of them commented that age 16 was too late to start taking cross-sex hormones, she said.

At the start of GnRHa treatment, all patients had normal bone mineral density, Delemarre-van de Waal reported. During GnRHa treatment, bone density gradually increased in the younger patients but slightly decreased in the older ones. However, after the teens received cross-sex hormones, bone density caught up, similar to the increase that occurs naturally in puberty, she said. All patients had normal or near-normal bone mass for their age after cross-sex hormone therapy.

"Remarkably, the highest bone mineral density was in the patients who had started hormonal intervention with GnRHa at an early pubertal stage," she said. "These findings reaffirm that halting puberty in gender-dysphoric adolescents is a responsible practice that will not harm bone health."

### Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.


ELSE PRESS RELEASES FROM THIS DATE:

Estrogen replacement therapy helps reduce anxiety in anorexia nervosa

2013-06-17
SAN FRANCISCO— Estrogen replacement therapy is associated with a significant decrease in anxiety symptoms among girls with anorexia nervosa, a new clinical trial finds. The results will be presented today at The Endocrine Society's Annual Meeting in San Francisco. "This is the first study to show that estrogen replacement ameliorates the tendency for anxiety in anorexia nervosa and may prevent increasing body dissatisfaction with weight gain," said the study's lead author Madhusmita Misra, MD, MPH, pediatric endocrinologist and associate professor of pediatrics at the ...

Vitamin D deficiency may raise allergy and asthma risk in obese children, teens

2013-06-17
One reason why obese children and teenagers are more likely to have hard-to-control asthma and allergies may be vitamin D deficiency, a new study finds. Results of the study will be presented Tuesday at The Endocrine Society's 95th Annual Meeting in San Francisco. "The increased risk for asthma and allergies, and for more severe cases of allergic disease, in overweight and obese adolescents has not previously been understood," said Candace Percival, MD, lead investigator and a pediatric endocrinology fellow at Walter Reed National Military Medical Center, Bethesda, MD. ...

Bushfires in north of Western Australia

2013-06-17
According to the Australian Government Bureau of Meterology, "In the warm, dry and sunny winter and spring, when grasses are dead and fuels have dried, northern Australia becomes most susceptible to bushfires. Intense high-pressure systems over South Australia producing strong southeast to northeast winds increase the risk of bushfires." Since Australia is heading into their winter as the northern climates head into summer, the north of Western Australia is ripe for bushfires. Many have already begun as evidenced from this satellite pass by NASA's Aqua satellite which ...

Adolescents' high-fat diet impairs memory and learning

2013-06-17
SAN FRANCISCO-- A high-fat diet in adolescence appears to have long-lasting effects on learning and memory during adulthood, a new study in mice finds. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. Adolescent mice fed a normal-calorie but high-fat diet became moderately obese but not diabetic, and they displayed significantly impaired spatial memory, according to the study authors, from CEU-San Pablo University (Universidad CEU-San Pablo) in Madrid. Spatial memory allows recording of information needed to navigate ...

Impaired heart function among obese children may help predict later disease

2013-06-17
SAN FRANCISCO-- Impaired heart function among obese children and adolescents may be an indicator of future heart disease, a new clinical trial finds. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. Obesity rates in developed countries worldwide are climbing among all age groups, including children. In the United States today, one-third of children are overweight or obese, which raises concerns about the effects of early weight gain on future health. Previous research showed that obesity in childhood can cause a type ...

Weight loss drug added to diet and exercise improves blood sugar control

2013-06-17
SAN FRANCISCO-- The new weight loss drug lorcaserin (Belviq) appears to improve blood sugar control in nondiabetic, overweight individuals, independent of the amount of weight they lose, a new study finds. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. Lorcaserin activates a serotonin receptor (5HT2C) in the brain believed to decrease appetite and promote a sense of fullness, thus encouraging decreased food consumption, said the study's principal investigator, Louis Aronne, MD, professor of clinical medicine at ...

Source of tumor growth in aggressive prostate cancer found

2013-06-17
SAN FRANCISCO-Researchers have discovered a molecular switch that explains, at least in part, how some fast-growing prostate cancers become resistant to hormone treatment, a new study conducted in human cell cultures and mice finds. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. A factor not normally found in the prostate, called Steroidogenic Factor 1, stimulates production of new steroid hormones and increases cell multiplication to fuel growth of the tumor, researchers from the University of Wisconsin-Madison, found. "This ...

Excessive salt consumption appears to be bad for your bones

2013-06-17
SAN FRANCISCO-- A high-salt diet raises a woman's risk of breaking a bone after menopause, no matter what her bone density is, according to a new study that will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. The Japanese study found that older women who consumed the highest amount of sodium had more than four times the risk of a nonvertebral fracture, or fracture at any site other than the spine. That finding held true even after the researchers made adjustments for many other characteristics that could affect fracture risk, said ...

Whole body vibration therapy increases bone strength

2013-06-17
SAN FRANCISCO-- A treatment known as whole body vibration therapy significantly increases bone strength among adolescents with cerebral palsy, a new clinical trial from New Zealand shows. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. Cerebral palsy affects more than half a million people in the United States. Caused by brain damage around the time of birth, the disorder affects muscle tone and movement, which can severely decrease the quality of life by making walking and other daily activities difficult. As movement ...

Osteoporosis drug may help treat advanced hormone-sensitive breast cancer

2013-06-17
A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco. The medication, bazedoxifene, which is approved in Europe under the brand name Conbriza for the treatment and prevention of postmenopausal osteoporosis, also reduced estrogen activity and estrogen receptor levels in cultured human breast cancer cells, the study authors reported. "Bazedoxifene, a known, safe drug approved ...

LAST 30 PRESS RELEASES:

Water as a waste management source: SEOULTECH researchers revolutionize catalytic plastic recycling

Antibiotics, vaccinations and anti-inflammatory medication linked to reduced risk of dementia

Study links popular herbicide to problems with infant health

Why you should (not) get a dog: the pros and cons of dog ownership

After millennia as carbon dioxide sink, more than one-third of Arctic-boreal region is now a source

The reversal of lipoprotein alterations in patients with ischaemic stroke offers new perspectives for cardiovascular disease research and management

Early diagnosis of bladder cancer, now conveniently at home

People who are autistic and transgender/gender diverse have poorer health and health care

Gene classifier tests for prostate cancer may influence treatment decisions despite lack of evidence for long-term outcomes

KERI, overcomes the biggest challenge of the lithium–sulfur battery, the core of UAM

In chimpanzees, peeing is contagious

Scientists uncover structure of critical component in deadly Nipah virus

Study identifies benefits, risks linked to popular weight-loss drugs

Ancient viral DNA shapes early embryo development

New study paves way for immunotherapies tailored for childhood cancers

Association of waist circumference with all-cause and cardiovascular mortalities in diabetes from the National Health and Nutrition Examination Survey 2003–2018

A new chapter in Roman administration: Insights from a late Roman inscription

Global trust in science remains strong

New global research reveals strong public trust in science

Inflammation may explain stomach problems in psoriasis sufferers

Guidance on animal-borne infections in the Canadian Arctic

Fatty muscles raise the risk of serious heart disease regardless of overall body weight

HKU ecologists uncover significant ecological impact of hybrid grouper release through religious practices

New register opens to crown Champion Trees across the U.S.

A unified approach to health data exchange

New superconductor with hallmark of unconventional superconductivity discovered

Global HIV study finds that cardiovascular risk models underestimate for key populations

New study offers insights into how populations conform or go against the crowd

Development of a high-performance AI device utilizing ion-controlled spin wave interference in magnetic materials

WashU researchers map individual brain dynamics

[Press-News.org] Medical intervention in transgender adolescents appears to be safe and effective